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Between 5 and 14% of human skin cells, separated by 
trypsinization, express HLA-DR antigen as detected by 
indirect immunofluorescence with monoclonal anti-DR 
antibody. To determine the source and structure of these 
DR molecules, skin cell suspensions were biosyntheti-
cally labeled with 35S-methionine and the radiolabeled 
DR molecules were analyzed by the method of two-di-
mensional polyacrylamide gel electrophoresis. The r e-
sults indicated the presence of h eavy, intermediate, and 
light chains indistinguishable from those of B lympho-
cyte DR. Gels in which DR immunoprecipitates from 
skin cells and a utologous lymphocytes were run simul-
taneously confirmed this finding. Thus, skin cells and 
lymphocytes synthesize HLA-DR antigen of identical 
charge and molecular weight. 
Most nucleated cells express HLA-A, B , and C a n t igens but 
t h e expression of HLA-DR antigen , t h e human analogue of t h e 
murine immune response associated (Ia ) antigens, apparently 
is more restricted [1]. Among t h e cells expressing HLA-DR are 
mononuclear leukocytes, endoth elial cells, certain bone marrow 
precursor cells, a nd epidermal cells [2-4]. The first report that 
murine epiderm al cells express Ia suggested th at the m ajority 
of t h ese cells demonstrate this an t igen [ 4]. However, s ubseq ue n t 
work on human epidermal cells indicated t hat only the Langer-
hans cell (LC) , a bone m arrow derived lymphoid cell which 
represents only 2-6% of th e total epidermal population, ex-
presses HLA-DR [5,6]. 
Recent investigations in our laboratory d emonstrated t h at 5-
14% of dispersed , human s kin cells express HLA-DR a ntigen 
(V. Morhenn, in preparation). The present studies were under-
taken in a n effort to a nalyze th e source a nd structure of t h ese 
DR molecules. Human skin cells, biosynthetically la beled with 
358-methionine, were subjected to immunoprecipitation with 
anti-DR a ntibody a nd the DR molecules analyzed by t h e 
m ethod of two-dimensional polyacryla mide gel e lectrophoresis 
(2D-PAGE) . The resul ts indicate t hat skin cells synthesize 
HLA-DR molecules of iden tical ch ar ge a nd molecular weight 
as those derived from au tologous bone m arrow derived lym -
phocytes. 
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USC: unfractionat~d skin ce lls 
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MATERIALS AND METHODS 
Antibodies 
Murine monoclonal ant i-HLA-DR antibodies were produced by so-
matic ce ll hybridization as previously reported (7). The antibody used 
in the current study, designated 2.06, is a gamma 2 immunoglobulin, 
which recognizes B lymphoblastoid cell lines and peripheral blood bone 
marrow-derived (B-cell) populations but fa ils to react with resting 
thymus-derived (T) cells or T cell lines. Antibody 2.06 recognizes all 
human B cells, regru·dless of HLA-DR type and precipitates B cell 
molecules of similru· molecular weight and charge as mw-ine Ia ant igens. 
T hese data suggest that the antibody is directed against a nonpoly-
morphic determinant of HLA-DR [8). T he preparation of ant ibod.v 
used in this study has a titer of 10; based on results of radioimmu no 
cell binding assays. 
Preparation of Shin Cells and Peripheral Blood Mononuclear 
Leuhocyte~; (PBML) 
Single cell suspensions of skin cell were prepared from normal skin 
obtained at surgery as described previously [9]. Briefly, trimmed skin 
was cut into 1 X 5 em strips and split-cut with a Castroviejo keratotome 
set at 0.1 mm. T he resul ting slices were treated for 60 min at 37°C with 
0.3% trypsin (Microbiological Assoc., Walkersville, MD) in 150 mM 
NaCI, 0.04% KCI, O. I% glucose, pH 7.3, and the resultant dispersed cells 
were suspended in RPM! 1640 medium supplemented with 10% heat 
inactivated pooled human serum, 100 units/ ml penicillin, !00 11g/ ml 
streptomycin, 50 !Lg/ ml gentamicin, 25 mM Hepes buffe1· and 2 mM L-
glu tamine (complete RPM!) medium. T his preparation is herein des-
ignated unfractionated skin cells (USC). PBML were sepru·ated from 
other blood components by Ficoll-Hypaque gradient centrifuga tion [10] 
and re uspended in complete RPMI medium. 
Assay for the Presence of Endothelial Cells 
Two ml aliquo~ of skin cells (10'; ceUs/ ml) were resuspended in 
Minimum Es entia! Medium supplemented with 10% heat inactivated 
pooled human serum, .1 !Lg/ ml choleratox in, 3.3 X 10- r. M isobutylme-
thylxanthine, 200 uni ts/ ml penicillin, 100 J.!g/ ml streptomycin, and 50 
11g/ ml gentamicin and plated on fibronectin-coated plates prepared as 
described (11). On days 1 and 4, the number of endothelial ee l.! colonies 
was estimated using an inverted phase microscope. 
Depletion of L C from Dispersed Shin Cell Preparations 
IgG antibody-coated bovine red blood cells (BRBC) were prepared 
as described [12]. USC were suspended at 4 X 10~' cells/ ml in TC199 
supplemented with 20% feta l calf serum (GIBCO, Grand Island, NY) 
and 50 11g/ ml gentamicin. This eel.! suspension was layered onto Ficoll-
Hypaque (9% Ficoll :33% Hypaque = 2.4: 1) and centrifuged for 30 min 
at 400 x g at 4°C [1 2]. The result ing pellet was assayed by BRBC 
binding (see below) and found to be 99.8% free ofLC. T he bone-mruTow 
derived LC and keratinocytes at the in te rface were washed, resus-
pended at lO;/ ml in supplemented TC199 and mixed with an eq ual 
volume of a 1% suspension of IgG antibody-coated BRBC. This mixture 
was pel!eted by centrifugation at 300 x g for 5 min, incubated on Ice for 
2-3 hr, gently resuspended, and layered on a second FicoU-Hypaq ue 
gradient. T he nonrosetted cells at the in terface were combined with 
the pellet of the first gradient. To determine the number of LC present 
following LC sepru·ation, USC and all fractions were rosetted (or 
rerosetted) as described [12]. USC conta ined 2% rosetting cells; on 
examining over 500 cells, the LC-depleted fractions showed less than 
0.2% rosettes. Viabili ty in al l fractions was determined by trypan blue 
exclusion and exceeded 70%. 
2D-PAGE 
Six to 18 hr after the initial prepamtion, skin cells or PBML were 
washed twice with PBS and radio labeled intem ally with ""S-methionine 
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for the length of time indicated [7]. Incorporation of label was stopped 
by addition of cold 2 mM methionine in PBS. T he cells were washed 
twice in this medium and the cell membrane was disrupted with 0.5% 
nonidet P-40 (NP-40) (Par ticle Data Laboratories, Elmhurst, Illinois) 
for 15 min at 4 oc in T ris-buffe red saline (1 50 mM NaCI/50mM Tris, 
0.02% NaN:~, pH 7.0). T he insoluble material was removed by centrif-
ugation at 15,000 x g for 3 min. 
To obtain DR molecules from radiolabeled cells, a two-step immu-
noprecipitation procedure was used in which the NP-40 cell lysates 
were incubated first with anti-DR antibody and then with Cowan 1 
strain staphylococcus. T he bound antigen complexes were elu ted as 
described and analysed by the method of 2D-PAGE [13]. In the first 
dimension, proteins were separated according to charge in nonequili-
brium pH gradient electrophoresis (NEPHGE) . The second dimension 
was run in 10% aery lam ide slab gels using a discontinuous Tris glycine/ 
sodium dodecyl sulfate gel system. T he slab gels were fixed, stained, 
dried, and exposed to Kodak NS-2T No-Screen x-ray fi lm. T he auto-
radiogmphs presented in this paper were the result of exposure for 7 
days for the PBML and 1- 3 weeks for skin cells. 
RESULTS 
2D-PAGE of HLA-DR Molecules from USC 
T he 2D-PAGE pattern ofHLA-DR immunoprecipitates from 
metabolically labeled skin cells displayed a heterogeneous set 
of spots in the range of 27,000 to 34,000 daltons distributed from 
the acidic to the basic end of the gel (Fig 1A ). This profile is 
sim ila r with respect to 'numbers, charge, a nd molecular weight 
to the HLA-DR proteins obtained from B lymphocytes or B 
lymphoblastoid cells lines (7]. We observed 3 groups of poly-
peptides: a 32,000 to 34,000 dalton set at the acidjc end of th e 
gel, a group of lower molecular weight spots (27,000 to 29,000 
daltons) at the basic end and a single basic ch ain of 31,000 
daltons. 
Comparison of 2D-PAGE of HLA-DR Synthesized by Skin 
Cells and PBML 
To deten;nine if DR molecules from skin cells and P BML 
were distinguishable, a mixture of the immunoprecipitates from 
skin cells and PBML were r un on a single gel (not shown). T he 
spots generated in this gel were iden t ical in posit ion and number 
to those seen on gels of the skin cell imm unoprecipitate or the 
PBML immunoprecipitate run separately (Fig 2). Although t he 
2D-PAGE patterns of DR fro m B cells and skin cells were 
similar, the intensity of the spots was noticeably less for a 
comparable number of skin cells . S imilar results were seen in a 
second experiment . 
Studies of LC-Depleted Skin Cells 
Unresolved in these experiments is whether the synt hesis of 
HLA-DR by skin cells was due entirely to LC or whether 
another skin cell type, e.g., endothelial cells, keratinocytes or 
contaminating lymphocytes also contributed to the synthesis of 
this antigen . Skin cells were depleted of lymphoid cells includ-
ing LC, and t he remaining cells analyzed by 2D -PAGE. The 
pattern of HLA-DR immunoprecipitates fro m metabolically 
labeled USC (Fig 1A ) and LC-depleted skin cells (Fig 1B ) 
obtained from the same individual showed t he same molecular 
profile, indicating t hat LC depleted skin cells still syn thesize 
detectable amounts of HLA-DR antigen. . 
Assay for the Presence of Endothelial Cells 
E ndothelial cells morphologically distinguishable from ker-
atinocytes were found both singly and in groups of 3-10 as eaTly 
as 24 hr after plating (11]. On day 4, about 0.2% of the plated 
cells formed endothelial cell colonies. Since the plating effi-
ciency of these cells is less than 100% the number of endothelia l 
cells in the original cell suspension is proba bly at least 1-2%. 
T hus, a small bu t significant number of endothelial cells a re 
present in the skin cell suspension. 
DISCUSSION 
T hese studies demonstrate that dispersed human skin cells 
synthesize HLA-DR molecules. The 2D -PAGE molecular pro-
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FIG 1. Two-dimensional gel electrophoresis of DR molecules syn-
thesized by unseparated human skin cells (USC) (A) or LC-depleted 
skin cells (B) obtained from the same donor. Four to 20 hr after 
trypsinization, USC labeled with "''S-methionine were extracted with 
NP-40, immunoprecipi tated with monoclonal anti-HLA-DR, and ana-
lyzed by 2D-PAGE. In the fi1·st dimension, proteins were separated 
according to charge in nonequilibrium pH gradient electrophoresis (NEPHGE) . The second dimension was run in 10% aery lam ide slab gels 
using a discontinuous Tris glycine/sodium dodecyl sulfate gel system. 
The acidic end of the gel is on the right. a, Actin is a 44 ,000 dalton 
molecule and serves as an in ternal marker fo r the ge l. The HLA-DR 
molecular pattern is composed of a group of acidic chains of 32,000 to 
34 ,000 daltons W. a 31,000 dalton invru·iant chain (Ji) and a set of 
27,000 to 29,000 dalton polpeptides (j ). T he electrophoretic profile of 
skin cell DR is similar to that obtained from B lymphocytes [7] and 
activated T lymphocytes [18]. The autoradiographs presented ru•e the 
resul t of exposure for 1 week. The USC suspension (A ) contained 2% 
Fe receptor-bearing cells; the LC-depleted fraction (B) contained less 
than 0.2% of such cells. 
file of HLA-DR immunoprecipitates from skin cells is ident ical 
to that of P BML obtained from the same donor. 
In murine bone marrow chimeras, the Ia ant igen expressed 
on epidermal cells is ident ical to that of the donor B-cells but 
not of the host B-cells, suggesting tha t only LC synthesize Ia 
[14,15]. Ho~ever, as pointed ou t by the latter aut hors, these 
results ar e consistent wit h the possibi lity t hat a nonbone-mru·-
row-derived cell in skin could synthesize Ia wit h a slow tumover 
time, and that this synt hesis could be masked by the synthesis 
of bone-marrow-derived cells in t he skin cell prepara tion [15]. 
P revious reports that Ficoll-H ypaque gradient centrifugation 
of skin cells depletes LC [12] were confirmed in the present 
study by enumeration of Fe receptor bearing cells. H owever, 
with a more sensitive technique utilizing immunoperoxidase 
staining and electron microscopy, we have determined that 
some lymphoid cells remain in the cell suspension after Ficoll-
H ypaque gradient centrifugation (V. Morhenn, in preparation). 
Thus, the synthesis ofHLA-DR molecules by LC-depleted skin 
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FIG 2. Two-dimensional gel electrophoresis of HLA -DR molecules 
synthesized by PBML (A) and skin cells (B) obta ined from the same 
donor. The autoradiographs presented ar e the resul t of exposure for 1 
week (PBML) and 3 weeks (skin cells). 
cells may be due to HLA-DR synthesis by th e few remaining 
lymphoid cells. Alternatively, the p ossibility exists that som e of 
th e HLA-DR a ntigen synthesized by LC-depleted s kin prepa-
rations is due to synt h esis by endot h elial cells, a cell-type 
known to express t his a ntigen (16]. To date, ne it h er biosy nth etic 
nor stru ctw-al studies of endot h elial cell DR h ave appear ed . A 
final possibility is that keratinocytes, the predomina n t cell type 
in all preparations, m ay synthesize DR. However , the relatively 
HUMAN SKIN CELLS SYNTHESIZE HLA-DR ANTIGEN 127 
weak incorporation of radiolabel suggests e ith er that the rate 
of DR syn t h esis per keratin ocyte is extr emely low or that only 
a small fractio n participate in biosyn thesis of DR. 
Regardless of th e sour ce, t h e 2D-PAGE pattern of skin cell 
DR was highly reproducible a nd never differed fro m the B-cell 
pattern. This finding is similar to findings r eported previously 
in t h e mouse and sh ould allow us to determine if benign or 
malignan t skin disorders ar e associated wit h unique or a ltered 
DR a ntigens. In t his regard, it is of inter est t hat human m ela-
noma lines syn th esize HLA-DR ligh t ch a ins of lower molecular 
weight t h an syn gen eic B lymph ocyte lines (17]. 
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